Short-Course Rifamycin and Pyrazinamide Treatment for Latent Tuberculosis Infection in Patients with HIV Infection

This publication has 9 references indexed in Scilit:

• Acceptability of Short-Course Rifampin and Pyrazinamide Treatment of Latent Tuberculosis Infection Among Jail Inmates
  Chest, 2001
• Rifampin and Pyrazinamide vs Isoniazid for Prevention of Tuberculosis in HIV-Infected PersonsAn International Randomized Trial
  JAMA, 2000
• Global Burden of Tuberculosis
  JAMA, 1999
• A Tuberculin Screening and Isoniazid Preventive Therapy Program in an Inner-City Population
  American Journal of Respiratory and Critical Care Medicine, 1999
• Twice weekly tuberculosis preventive therapy in HIV infection in Zambia
  AIDS, 1998
• Antituberculosis Drug–induced Hepatotoxicity
  American Journal of Respiratory and Critical Care Medicine, 1998
• Randomised trial of isoniazid versus rifampicin and pyrazinamide for prevention of tuberculosis in HIV-1 infection
  The Lancet, 1998
• Treatment of tuberculosis and tuberculosis infection in adults and children. American Thoracic Society and The Centers for Disease Control and Prevention.
  American Journal of Respiratory and Critical Care Medicine, 1994
• A Prospective Study of the Risk of Tuberculosis among Intravenous Drug Users with Human Immunodeficiency Virus Infection
  New England Journal of Medicine, 1989